Gujarat Gas shares fall 2% as crude prices spike amid Israel-Iran war escalation
Shares of Gujarat Gas Ltd declined 2.01% to ₹467.05 in Friday's early session, down from a previous close of ₹476.65. The stock followed broader pressure on city gas distribution companies, as global crude oil prices surged over 10% following Israel's preemptive military strike on Iran.
Gujarat Gas, which supplies piped natural gas (PNG) and compressed natural gas (CNG), often bears the brunt of rising global energy costs, especially when LNG spot prices rise in tandem with crude oil benchmarks. As WTI and Brent crude futures soared past $75 and $77 per barrel respectively, investor concerns mounted over potential supply disruptions and rising input costs.
The spike in energy prices comes amid fears of escalation, with analysts warning that a broader conflict involving Iran may strain global oil and gas logistics, especially if it impacts the Strait of Hormuz, through which nearly 20% of the world's oil passes.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
an hour ago
- CNBC
Oil rises as U.S.-EU deal lifts trade optimism
Oil prices rose on Monday after the U.S. reached a trade deal with the European Union and may extend a tariff pause with China, reducing concerns that potentially higher levies would limit economic activity and impact fuel demand. Brent crude futures inched up 22 cents, or 0.32%, to $68.66 a barrel by 0035 GMT while U.S. West Texas Intermediate crude was at $65.38 a barrel, up 22 cents, or 0.34%. The U.S.-European Union trade deal and a possible extension in U.S.-China tariff pause are supporting global financial markets and oil prices, IG markets analyst Tony Sycamore said. The United States and the European Union struck a framework trade agreement on Sunday that will impose a 15% import tariff on most EU goods, half the threatened rate. The deal averted a bigger trade war between two allies that account for almost one-third of global trade and could crimp fuel demand. Also, senior U.S. and Chinese negotiators will meet in Stockholm on Monday aiming to extend a truce keeping sharply higher tariffs at bay ahead of the August 12 deadline. Oil prices settled on Friday at their lowest in three weeks as global trade concerns and expectations of more oil supply from Venezuela weighed. Venezuela's state-run oil company PDVSA is getting ready to resume work at its joint ventures under terms similar to Biden-era licenses, once U.S. President Donald Trump reinstates authorizations for its partners to operate and export oil under swaps, company sources said. Though prices were up slightly on Monday, the prospect of OPEC+ further easing supply curbs limited the gains. A market monitoring panel of the Organization of the Petroleum Exporting Countries and their allies is set to meet at 1200 GMT on Monday. It is unlikely to recommend altering existing plans by eight members to raise oil output by 548,000 barrels per day in August, four OPEC+ delegates said last week. Another source said it was too early to say. The producer group is keen to recover market share while summer demand is helping to absorb the extra barrels. JP Morgan analysts said global oil demand rose by 600,000 bpd in July on year, while global oil stocks rose 1.6 million bpd. In the Middle East, Yemen's Houthis said on Sunday they would target any ships belonging to companies that do business with Israeli ports, regardless of their nationalities, as part of what they called the fourth phase of their military operations against Israel over the Gaza conflict.
Business Upturn
an hour ago
- Business Upturn
Why are Laurus Labs shares up over 2% today? Explained
By Aditya Bhagchandani Published on July 28, 2025, 09:27 IST Shares of Laurus Labs Ltd surged over 2% to ₹856.25 in early trade on Monday, making it one of the top gainers on the NSE. The sharp upmove comes on the back of a stellar Q1 performance, a major land allotment for expansion, and bullish commentary from top brokerages. Here's what's driving the stock higher: 1. Blockbuster Q1 FY26 Results Laurus Labs posted a net profit of ₹163 crore, up a massive 1,185% YoY from ₹13 crore a year ago. Revenue : ₹1,570 crore (up 31% YoY) : ₹1,570 crore (up 31% YoY) EBITDA : ₹389 crore (up 127% YoY) : ₹389 crore (up 127% YoY) EBITDA Margin: Expanded significantly YoY, reflecting strong operating leverage This marked the company's third consecutive earnings beat, with particularly robust performance in the CDMO (Contract Development and Manufacturing Organization) and ARV (antiretroviral) verticals. 2. Strategic Land Allotment for Laurus Pharma Zone The Andhra Pradesh government allotted 531.77 acres to Laurus in IP Rambilli Phase-II (Anakapalli District) for the development of a Laurus Pharma Zone (LPZ). Planned investment : ₹5,630 crore : ₹5,630 crore Job creation target : 6,350 people : 6,350 people Phased execution over 8 years This land is crucial for Laurus' long-term growth strategy, giving it the physical base to scale up manufacturing capabilities across API, formulations, and novel therapies. 3. Bullish Broker Commentary Motilal Oswal (MOSL) has maintained a 'Buy' rating, raising the target price to ₹970 (from ₹860) Upgraded gross margin guidance to 55–60% (from 50–55%) Strong CDMO visibility and pipeline Raised earnings estimates by 16% for FY26 and 7% for FY27 has maintained a rating, raising the (from ₹860) Antique Stock Broking gave a more balanced view, maintaining a 'Hold' but still raising the target to ₹700 (from ₹520), citing: Limited visibility in CDMO contracts ARV outlook steady but not exceptional Scale-up challenges in Bio CDMO segment gave a more balanced view, but still raising the target to ₹700 (from ₹520), citing: Still, the firm expects ~16% revenue CAGR from FY25 to FY28, and EBITDA margins to rise from 19% to 30% over the same period. Segmental Strength & Capex Plans The CDMO business is growing rapidly , now contributing more meaningfully to revenues , now contributing more meaningfully to revenues The company is also building a new Gene/ADC facility in Hyderabad and a microbial fermentation plant in Vizag and a Plans to invest ₹5,000 crore over the next 5 years, with net debt/EBITDA expected to stay in the 2.2x–2.5x range Market Snapshot: Stock Price : ₹856.25 (up 2.21%) : ₹856.25 (up 2.21%) 52-week range : ₹417.70 – ₹855.00 : ₹417.70 – ₹855.00 Market Cap : ₹460.32 billion : ₹460.32 billion P/E Ratio: 90.53 Laurus Labs' sharp rally today is driven by optimism around its blockbuster Q1 numbers, the government-backed land allotment, and analyst upgrades, all of which point to a long runway for growth. While near-term execution challenges remain, the market appears to be betting on Laurus' transformational expansion strategy and strong positioning in high-value pharma segments. Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Please consult your financial advisor before making any investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
an hour ago
- Business Upturn
Kotak Mahindra Bank shares drop over 5% after Q1 profit falls 47.5% YoY to Rs 3,282 crore, GNPA at 1.48% vs 1.39% QoQ
By Aman Shukla Published on July 28, 2025, 09:18 IST Kotak Mahindra Bank shares tumbled over 5% on Monday after the private lender posted a sharp 47.5% year-on-year (YoY) drop in net profit for the quarter ended June 30, 2025 (Q1 FY26). As of 9:16 AM, the shares were trading 5.18% lower at Rs 2,014.50. The bank reported a consolidated profit of ₹3,281.68 crore for the quarter, down from ₹6,249.82 crore in Q1 FY25, largely due to the absence of a one-time exceptional gain of ₹3,519.90 crore recorded in the same quarter last year. Despite the profit decline, core business metrics remained steady. Net Interest Income (NII) rose 6% YoY to ₹7,259 crore, reflecting healthy lending activity and stable margins. Total income for the quarter stood at ₹16,916 crore, up from ₹15,675 crore a year ago. Operating profit before provisions grew to ₹5,563.69 crore from ₹5,254.11 crore YoY. However, higher provisions and contingencies, which surged to ₹1,207.76 crore from ₹578.48 crore YoY, weighed on overall profitability. Asset quality showed a slight deterioration sequentially. Gross NPAs rose to ₹6,637.70 crore (1.48%) from ₹5,477.15 crore (1.39%), while Net NPAs stood at ₹1,530.93 crore (0.34%) versus ₹1,376.33 crore (0.35%) in the previous quarter. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
